Connect to other sites within the UBM Medica Network
Uneven DMARD Use in RA May Not Worsen Short-term Outcomes
Lack of complete and consistent adherence to DMARD regimens may not be as adverse to outcomes as you think.
FDA Re-Approves Formerly Withdrawn Opioid Shown Effective Against OA Pain
Pfizer expects to release Embeda (morphine sulfate and naltrexone hydrochloride), approved in 2009 based on osteoarthritis studies but withdrawn by another firm in 2011 due to concerns over abuse, sometime early next year.
RA Patients Gain the Upper Hand With Exercises
Tailored exercises are effective in retraining and restoring hand function in rheumatoid arthritis.
Rheumatology Patients Seek Greater Voice in Treatment Decisions
More calls for rheumatologists to spend time listening to patients: Over half of respondents to a Dutch survey report too little say in decisions about treatments for RA and other conditions.
Interstitial Pneumonia? Rheumatic Disease Has Better Odds Than Idiopathic
Survival odds for interstitial pneumonia are better when the condition is comorbid with rheumatoid arthritis or systemic sclerosis than when the pulmonary fibrosis is idiopathic.
Be Alert for VTE Risk in Giant Cell Arteritis
Risks for venous and pulmonary thromboembolism are increased dramatically in patients with giant cell arteritis, especially in the first year after diagnosis.
In-Hospital Biopsy Drives GCA Patient Temporarily Crazy
A patient with giant cell arteritis, slated for temporal artery biopsy, ended up with in-hospital delirium. Why?
By clicking Accept, you agree to become a member of the UBM Medica Community.